Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
5.12
+0.08 (1.59%)
Apr 1, 2025, 2:45 PM CST
SHA:600998 Revenue
Jointown Pharmaceutical Group had revenue of 36.26B CNY in the quarter ending September 30, 2024, with 3.57% growth. This brings the company's revenue in the last twelve months to 149.20B, down -1.74% year-over-year. In the year 2023, Jointown Pharmaceutical Group had annual revenue of 150.14B with 6.92% growth.
Revenue (ttm)
149.20B
Revenue Growth
-1.74%
P/S Ratio
0.17
Revenue / Employee
4.96M
Employees
30,100
Market Cap
25.15B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 150.14B | 9.72B | 6.92% |
Dec 31, 2022 | 140.42B | 18.02B | 14.72% |
Dec 31, 2021 | 122.41B | 11.55B | 10.42% |
Dec 31, 2020 | 110.86B | 11.36B | 11.42% |
Dec 31, 2019 | 99.50B | 12.36B | 14.19% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 26.00B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |